Pharmabiz4h
Meril Life Sciences empowers healthcare leaders with digital technologies to build supply chain efficiency
In line with their commitment to improve healthcare efficacy, Meril Life Sciences recently carried out a two-day practitioner ...
Pharmabiz50m
MaaT Pharma completes recruitment in ARES phase 3 trial for MaaT013 to treat acute graft-versus-host disease
MaaT Pharma, a clinical-stage biotechnology company, announced full recruitment of its phase 3 clinical trial designed to evaluate efficacy and safety of its lead asset MaaT013 in the treatment of ...
Pharmabiz2h
CUTS raised concerns regarding the effectiveness and proportionality of the proposed rules on Anti-Tobacco Disclaimers by the MoHFW
CUTS International, a prominent consumer health advocacy group, has submitted a detailed set of comments and suggestions on the proposed “Cigarette and Other Tobacco Products (Prohibition of ...
Pharmabiz7h
Adayu unveils podcast series ‘Adayulogues’ on YouTube to raise awareness on mental health
Adayu unveils podcast series ‘Adayulogues’ on YouTube to raise awareness on mental health: Our Bureau, Bengaluru Wednesday, October 16, 2024, 16:30 Hrs [IST] Adayu, a Fortis G ...
Pharmabiz7h
Lipella Pharmaceuticals’ innovative liposomal drug delivery platform receives US patent
Lipella Pharmaceuticals’ innovative liposomal drug delivery platform receives US patent: Pittsburgh Wednesday, October 16, 2024, 17:00 Hrs [IST] Lipella Pharmaceuticals Inc., a ...
Pharmabiz8h
OneSource CDMO receives equity commitments of US$ 95 mn from marquee investors at a pre-money equity valuation of US$ 1.65 bn
OneSource CDMO receives equity commitments of US$ 95 mn from marquee investors at a pre-money equity valuation of US$ 1.65 bn: Our Bureau, Bengaluru Wednesday, October 16, 2024, 1 ...
Pharmabiz11h
Bayer seeks European approval for darolutamide in combo with ADT in patients with metastatic hormone-sensitive prostate cancer
Bayer seeks European approval for darolutamide in combo with ADT in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, October 16, 2024, 13:00 Hrs [IST] ...
Pharmabiz14h
Bayer submits marketing authorization application to EMA for elinzanetant to treat moderate to severe vasomotor symptoms
Bayer submits marketing authorization application to EMA for elinzanetant to treat moderate to severe vasomotor symptoms: Berlin Wednesday, October 16, 2024, 10:00 Hrs [IST] Bayer ...
Pharmabiz8h
GBMA recommends rodent control as key GMP strategy for pharma industry amid imminent leptospirosis and plague threats
Shardul Nautiyal, Mumbai Wednesday, October 16, 2024, 16:05 Hrs [IST] ...
Pharmabiz15h
UK’s life sciences sector to receive a £279 million boost to tackle significant health challenges
The UK’s world leading life sciences sector will receive a £279 million boost to tackle significant health challenges, with an intent expressed by Lilly, the world’s largest pharmaceutical company, to ...
Pharmabiz8h
LEO Pharma launches Anzupgo cream in Germany to treat patients with chronic hand eczema
LEO Pharma A/S, a global leader in medical dermatology, announces the launch of Anzupgo (delgocitinib) cream in Germany for the treatment of adult patients with moderate to severe chronic hand eczema ...
Pharmabiz10h
Government collaborating with international organisations to harmonise regulatory requirements, says MoS of ministry of health
Government collaborating with international organisations to harmonise regulatory requirements, says MoS of ministry of health: Our Bureau, New Delhi Wednesday, October 16, 2024, ...